HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PPARdelta agonist attenuates alcohol-induced hepatic insulin resistance and improves liver injury and repair.

AbstractBACKGROUND/AIMS:
Chronic ethanol exposure impairs liver regeneration due to inhibition of insulin signaling and oxidative injury. PPAR agonists function as insulin sensitizers and anti-inflammatory agents. We investigated whether treatment with a PPARdelta agonist could restore hepatic insulin sensitivity, survival signaling, and regenerative responses vis-a-vis chronic ethanol feeding.
METHODS:
Adult rats were fed isocaloric liquid diets containing 0% or 37% ethanol, and administered a PPARdelta agonist by i.p. injection. We used liver tissue to examine histopathology, gene expression, oxidative stress, insulin signaling, and regenerative responses to 2/3 hepatectomy.
RESULTS:
Chronic ethanol feeding caused insulin resistance, increased oxidative stress, lipid peroxidation, DNA damage, and hepatocellular injury in liver. These effects were associated with reduced insulin receptor binding and affinity, impaired survival signaling through PI3K/Akt/GSK3beta, and reduced expression of insulin responsive genes mediating energy metabolism and tissue remodeling. PPARdelta agonist treatment reduced ethanol-mediated hepatic injury, oxidative stress, lipid peroxidation, and insulin resistance, increased signaling through PI3K/Akt/GSK3beta, and enhanced the regenerative response to partial hepatectomy.
CONCLUSIONS:
PPARdelta agonist administration may attenuate the severity of chronic ethanol-induced liver injury and ethanol's adverse effects on the hepatic repair by restoring insulin responsiveness, even in the context of continued high-level ethanol consumption.
AuthorsMaoyin Pang, Suzanne M de la Monte, Lisa Longato, Ming Tong, Jiman He, Rajeeve Chaudhry, Kevin Duan, Jiyun Ouh, Jack R Wands
JournalJournal of hepatology (J Hepatol) Vol. 50 Issue 6 Pg. 1192-201 (Jun 2009) ISSN: 1600-0641 [Electronic] Netherlands
PMID19398227 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • 4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid
  • Insulin
  • PPAR delta
  • Phenoxyacetates
  • Ethanol
  • Receptor, IGF Type 1
Topics
  • Animals
  • DNA Damage
  • Ethanol (toxicity)
  • Gene Expression (drug effects)
  • Insulin (metabolism)
  • Insulin Resistance
  • Lipid Peroxidation (drug effects)
  • Liver (drug effects, injuries, pathology, physiopathology)
  • Liver Regeneration (drug effects)
  • Male
  • Oxidative Stress (drug effects)
  • PPAR delta (agonists)
  • Phenoxyacetates (pharmacology)
  • Rats
  • Rats, Long-Evans
  • Receptor, IGF Type 1 (metabolism)
  • Signal Transduction (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: